Urine Metabolites in the Diagnosis of Disease | MicrobiomeTrials← Back to trialsNCT06710067
Urine Metabolites in the Diagnosis of Disease
RecruitingOBSERVATIONAL
Trial Details
Start: 2024-10-01Est. Completion: 2025-09
Enrollment target: 1,250 participants Locations- Unio Health Partners (Gastroenterology), Encinitas, California, United States
- Digestive Health Associates, Santa Monica, California, United States
- Westside Gastro Care, Santa Monica, California, United States
- Bass Medical Group (Gastroenterology), Walnut Creek, California, United States
Other microbiome trials you might be interested in
Colorectal NeoplasmsNeoplasmsIntrahepatic CholangiocarcinomaAdrenocortical CarcinomaMetastasis, Neoplasm
Background:
Cancers that begin in the colon, adrenal glands, or bile ducts may spread to the liver. These liver tumors …
Bethesda, United StatesEst. completion Dec 31, 2029
Breast CancerDiabetesColon CancerCardiovascular Disease
This study will examine what methods work best for encouraging Mexican-American family members to talk about their risk …
Colorectal NeoplasmsGastric NeoplasmsCholangiocarcinomaBile Duct CancerPancreas Cancer
Background:
\- Recent advances in cancer research have led to new therapies to treat the disease. It is important to co…
Bethesda, United StatesEst. completion Jun 30, 2035